Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

0
Player Avatar lg7691 (25.37) Submitted: 7/21/2013 1:34:10 PM : Outperform Start Price: $42.71 BMY Score: +6.45

7/21/13 44.19 drug stock

Featured Broker Partners


Advertisement